Procter & Gamble Company (PG)

The data on Procter & Gamble Company's number of days of payables over various periods indicates fluctuations in its accounts payable policy and payment practices. Initially, in the fiscal year ending June 30, 2020, the company’s days of payables were approximately 125 days, with minimal variation through the subsequent quarter and year. The figure rose steadily, reaching a peak of around 135 days in September 2021, and maintained elevated levels through the end of 2021 and mid-2022, experiencing slight fluctuations but generally remaining above 125 days.

From late 2022 onwards, a downward trend is observable, with the days of payables decreasing to approximately 120 days by the end of December 2022, and reaching a low of about 117 days in March 2023. This suggests a potential tightening of payment policies or improved cash management during this period. However, in the subsequent quarters of 2023 and into 2024, the number of payable days increased again, reaching over 137 days in June 2024 and September 2024, indicating a possible extension of payment periods or strategic management of supplier terms.

By the end of the most recent period, December 2024, the days of payables are close to earlier levels, around 128 days, with a slight increase to approximately 129 days in March 2025. Overall, the trend exhibits periods of both extension and contraction in payables days, reflecting adjustments in the company's working capital management and supplier payment strategies over time.

This variability underscores a dynamic approach to managing short-term liabilities, likely aligned with broader financial and operational considerations, including liquidity positions, supply chain relationships, and strategic cash flow optimization.